SPARC ameliorates ovarian cancer-associated inflammation.
about
RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancerDinosaurs and ancient civilizations: reflections on the treatment of cancerLoss of SPARC in bladder cancer enhances carcinogenesis and progression.Differential roles of uPAR in peritoneal ovarian carcinomatosisNeoplasia: the second decade.Towards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational researchSPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.Phenotypic and functional delineation of murine CX(3)CR1 monocyte-derived cells in ovarian cancerSPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier propertiesSmac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.Ovarian tumor-induced T cell suppression is alleviated by vascular leukocyte depletion.The War on Cancer rages on.Roles of SPARC in urothelial carcinogenesis, progression and metastasis.Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.Stromal expression of SPARC in pancreatic adenocarcinoma.Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.Microenvironment-centred dynamics in aggressive B-cell lymphomas.Osteonectin expression in surrounding stroma of craniopharyngiomas: association with recurrence rate and brain infiltration.Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization.Role of tumor microenvironment in ovarian cancer pathobiology.SPARC Inhibits Metabolic Plasticity in Ovarian CancerRole of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
P2860
Q24608385-446253E4-9807-4115-B768-BFEA72E10C89Q24623746-0E5A59AB-18DA-4B05-BF8D-C6F8A5DCD7C9Q24628746-CFF14563-893B-41C4-B541-80E56F035877Q30422650-04DBD3E8-DD0B-4B56-8626-47626448321BQ30426956-CF60415E-D58D-46AE-A394-3F66F6DAF9CFQ30484000-C94BF89F-68C7-4BCE-8335-EB6F3BDB368DQ33576391-2721FF90-ED40-4C1C-85D4-A74458D1A140Q33983083-695BCFB2-C401-42CC-B187-A58AFBE46107Q34042603-BD5D6333-6461-4EA7-89E8-CEF25602FCDDQ35142408-6B4B8CAD-C886-447C-955F-4987FAE4D6B6Q35679638-F2433010-B107-41EB-973F-162B30B3C2F2Q37149626-D6386FC3-EE5B-436B-8ECB-7D09B083A784Q37200471-C69E4BFD-5D3E-441C-93FE-9CAB4F9796DFQ37223975-FD2BD835-F7F4-4553-9F24-ED382531BC9AQ37357090-B6E602C0-D4CA-4FB5-A829-C2254E0C9498Q37429892-62816157-DF13-45FF-9C63-AF2CACF74A3EQ37478602-D81A93F9-DFA1-4809-80C0-C728D3C1C3D8Q37687199-C345B760-D80A-4847-9F56-7B4AB2CA2949Q38101074-C0508BA5-CCA5-449A-B185-5A068C7092B3Q38108253-3D1C07EB-B9DF-4284-8811-C65E59A5B58EQ38172849-A52050FE-EA66-482A-8C84-E2D6139202D8Q38757854-2811D233-05CC-495D-9D87-CD476289E492Q38985417-06897465-E330-439D-9A6E-630E9B991857Q38991458-729EA3FF-222B-494B-A95D-39C8FD2EECD3Q41570171-8D26C7A9-12C3-47C0-BBC2-0AE06F75ED11Q44641509-8823D389-294B-4334-9FC9-7565194CC71EQ49991844-E0BF1FB4-292E-4FE7-BCB7-9E3E355291CDQ55078149-49E7DF95-A52B-4AB6-8060-BF6A61745F43Q58551785-0249BF4F-4F67-47A1-91F1-45A6A61D4D55Q58724750-CF4DB6B7-3C70-4F24-B96E-6FFF101FC5B5
P2860
SPARC ameliorates ovarian cancer-associated inflammation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
SPARC ameliorates ovarian cancer-associated inflammation.
@en
type
label
SPARC ameliorates ovarian cancer-associated inflammation.
@en
prefLabel
SPARC ameliorates ovarian cancer-associated inflammation.
@en
P2093
P2860
P356
P1433
P1476
SPARC ameliorates ovarian cancer-associated inflammation.
@en
P2093
Ahmed A Elmarakby
David J Fulton
John D Imig
Kouros Motamed
Neveen A Said
P2860
P304
P356
10.1593/NEO.08672
P577
2008-10-01T00:00:00Z